Sort by
Refine Your Search
-
Listed
-
Employer
- Stony Brook University
- Baylor College of Medicine
- Northeastern University
- Oak Ridge National Laboratory
- Texas A&M University
- University of Colorado
- Argonne
- Carnegie Mellon University
- Duke University
- East Carolina University
- Georgia State University
- Medical College of Wisconsin
- New York University
- Stanford University
- The Ohio State University
- The University of Memphis
- University of Central Florida
- University of Houston
- University of Minnesota
- University of North Carolina at Chapel Hill
- University of Oklahoma
- University of Oregon
- Virginia Tech
- 13 more »
- « less
-
Field
-
supervision of PI Calina Copos and will engage in collaborative work with cell and developmental biologists. Expertise in agent-based models, continuum PDE descriptions, dynamical systems, and/or ML-based
-
modeling and simulation tools DESIRED QUALIFICATIONS: Experience using NONMEM, R, Monolix and/or other platforms for analysis of clinical and/or preclinical pharmacology data; development of web-based tools
-
ecological systems with frequency-dependent selection. Planned projects use dynamical systems, stochastic differential equations and agent-based models, statistical methods for parameter inference, network and
-
, and to interact regularly with Dr. Jonathan Campbell to design and execute experimental studies involving animal and cell-based models of metabolic disease. In addition, will also perform the following
-
independently to develop therapeutic agents against mutant p53 and other oncoproteins using artificial intelligence, monoclonal antibodies, and DNA vaccines. The positions offer a unique team-based science
-
Expert in advanced machine learning such as multi-agent generative AI, LLMs, Diffusion models, and traditional machine learning techniques Expert in CALPHAD-based ICME techniques Expert in combining
-
and Performance of Research Experiments (75% of Time Spent) Mechanism based discovery of cancer therapeutics. Characterization of metabolic processes of leukemia stem cells. Use of animal model systems
-
well as high-throughput screening strategies to identify small molecular compounds that might serve as novel therapeutic agents in disease using cell culture, kidney organoid, and mouse models. Successful
-
and conducting experiments using various mouse models of disease. This position involves investigating how bacterial agents modulate immune responses to develop novel therapeutic strategies, with a
-
. Construct machine-learning models for feature-based molecular property prediction and drive the inverse design of ligands with engineered properties. Develop machine-learned interatomic potentials trained